Autonomous Reanimation and Evacuation (AREVA) Research Program
The AREVA Team
Andriy “Andrew” Batchinsky, MD, Founder and Director, AREVA
Teryn Roberts, PhD, Principal Investigator
Yanyi Zang, PhD, Co-Investigator
Antoine Persello, PhD, Co-Investigator
George Harea, PhD Candidate
Daniel Wendorf, Laboratory Manager
Brendan Beely, RRT, Research Coordinator
AREVA is a research program and laboratory servicing 12 combat casualty care-relevant research grants carried out at prolonged field-care intensive care unit studies for 72 hours. AREVA executes benchtop science and ex vivo experiments up to 24 hours in duration in a dedicated plug-and-play circulation laboratory. AREVA performs large animal trauma studies with up to 96 hours of round-the-clock intensive care, conducted to human ICU standards of care. With a state-of-the-art coagulation laboratory and dedicated clinical diagnostic laboratory tools and point-of-care devices, AREVA can perform all phases of study from concept design through injured and un-injured large animal experiments.
Animal Intensive Care Unit
The animal intensive care unit is made of a fully self-enclosed space with dedicated HEPA filtration. It is equipped with state-of-the-art ICU patient care equipment to provide round-the-clock care to human standards of care. The Animal ICU is currently built to conduct two large animal experiments simultaneously, with plans for future expansion to 4 beds, including BSL 2 capability.
Unique Research Areas
Small and Large Animal Research
Point of Injuries Interventions
Ex-vivo and In-vivo Research
Selective organ perfusion
AREVA applies ECLS therapy to organs and traumatically amputated limbs to enable a longer time before re-attachment. This novel work is conducted in a plug-and-play ex vivo circulation laboratory using donor blood.
All Forms of ECLS
AREVA is investigating earlier and wider applications of ECLS technologies in various configurations to improve patient outcomes.
AREVA tests ground-breaking ideas and approaches to limit or remove anticoagulation and make biologically friendly interfaces suitable without the need to administer any anticlotting agents.
Infection and Inflammation Research
Pre-clinical Multi-day Studies
Pre-FDA and GLP Research
Combat Relevant Research
AREVA is committed to reducing mortality in combat casualties by examining the most severe non-survivable injuries.
AREVA has a strong record of successful collaborations with universities, companies, government agencies, clinical care teams, and industry leaders at all phases of research.Collaborate with AREVA
COMMERCIAL & CLINICAL
Geneva researchers at AREVA have published scientific publications in areas including Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Life Support, Combat Care, Regenerative Medicine, Trauma Care, Wound Healing and more.Learn More